Ling Rui Pharmaceutical announced that the company recently received the “Drug Registration Certificate” for metformin hydrochloride extended-release tablets approved and issued by the State Drug Administration.
羚锐制药：盐酸二甲双胍缓释片获得药品注册证书
Ling Rui Pharmaceutical: Metformin Hydrochloride Extended-Release Tablets Obtain Drug Registration Certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.